Prevalence of venous thrombosis following venovenous extracorporeal membrane oxygenation in patients with severe respiratory failure

Critical Care Medicine

Volumn 43, Issue 12, 2015, Pages e581-e584

  Cooper, Eve ^a   Burns, Janis ^a   Retter, Andrew ^a   Salt, Gavin ^a   Camporota, Luigi ^a   Meadows, Christopher I S ^a   Langrish, Christopher C J ^a   Wyncoll, Duncan ^a   Glover, Guy ^a   Ioannou, Nicholas ^a   Daly, Kathleen ^a   Barrett, Nicholas A ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

acute respiratory distress syndrome; cannula related thrombosis; deep vein thrombosis prevalence; severe respiratory failure; venovenous extracorporeal membrane oxygenation

Indexed keywords

HEPARIN;

ADULT; ANTICOAGULATION; ARTICLE; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION; ADVERSE EFFECTS; CATHETERIZATION; ECHOGRAPHY; MIDDLE AGED; PROCEDURES; RESPIRATORY INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTER; VENOUS THROMBOSIS;

ADULT; CATHETERIZATION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS; VENOUS THROMBOSIS;

EID: 84947290484     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001277     Document Type: Article

References (9)

1. Peek GJ, Mugford M, Tiruvoipati R, CESAR Trial Collaboration Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 2009 374 1351 1363
2. Noah MA, Peek GJ, Finney SJ, Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011 306 1659 1668
3. Paden ML, Conrad SA, Rycus PT, ELSO Registry Extracorporeal Life Support Organization Registry Report 2012. ASAIO J 2013 59 202 210
4. Lequier L, Annich G, Al-Ibrahim O, ELSO Anticoagulation Guidelines 2014 Michigan ELSO
5. Zangrillo A, Biondi-Zoccai G, Landoni G, Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: A systematic review and meta-Analysis including 8 studies and 266 patients receiving ECMO. Crit Care 2013 17 R30
6. PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group Cook D, Meade M, PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 2011 364 1305 1314
7. Merrer J, De Jonghe B, Golliot F, French Catheter Study Group in Intensive Care Complications of femoral and subclavian venous catheterization in critically ill patients: A randomized controlled trial. JAMA 2001 286 700 707
8. Shafii AE, Brown CR, Murthy SC, High incidence of upper-extremity deep vein thrombosis with dual-lumen venovenous extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 2012 144 988 989
9. Tauber H, Ott H, Streif W, Extracorporeal membrane oxygenation induces short-Term loss of high-molecular-weight von Willebrand factor multimers. Anesth Analg 2015 120 730 736